Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Why Moderna Shares Are Rising Again Today - Moderna (NASDAQ:MRNA)
11:59am, Wednesday, 14'th Dec 2022
Moderna Inc MRNA shares are trading higher by 8.5% to $214.34 on continued upward momentum after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary efficacy
Is Moderna Stock a Buy After Its Impressive Cancer Vaccine Results?
07:45am, Wednesday, 14'th Dec 2022
Moderna could have a winner with its personalized cancer vaccine. But the company also faces big questions.
Moderna rockets higher as vaccine offers glimpse of 'new paradigm ' in cancer treatment
03:27am, Wednesday, 14'th Dec 2022
Moderna shares rose by almost 20% overnight in the US an experimental cancer vaccine based on its messenger RNA (MRNA) technology boosted survival rates by over 40% in a trial. Shares in pharma compan
Moderna, Merck stocks boosted amid joint cancer vaccine trials
04:52pm, Tuesday, 13'th Dec 2022
Yahoo Finance health correspondent Anjalee Khemlani joins the Live show to review Moderna and Merck shares following positive results seen in their joint cancer vaccine trial.
Melanoma vaccine data should make investors more positive on Moderna, says Jefferies' Michael Yee
04:47pm, Tuesday, 13'th Dec 2022
Michael Yee, Jefferies, joins 'Closing Bell' to discuss Moderna popping on strong Melanoma vaccine data.
Moderna Soars On Cancer Vaccine News: Here's What To Watch Going Forward - Moderna (NASDAQ:MRNA)
03:33pm, Tuesday, 13'th Dec 2022
Moderna, Inc MRNA gapped up 13% to start the trading day on Tuesday and was skyrocketing an additional 12% intraday after announcing that its Merck & Co, Inc MRK partnered cancer vaccine met the prima
Encouraging Trial Data Sends Moderna Stock Soaring
02:18pm, Tuesday, 13'th Dec 2022
Moderna Inc (NASDAQ:MRNA) is up 23.6% at $204.04 at last check, after a mid-stage trial showed the combination of its experimental melanoma vaccine and Merck's (MRK) immunotherapy Keytruda lowered the
Why Moderna Stock Is Popping Over 20% Today
02:15pm, Tuesday, 13'th Dec 2022
Moderna Stock is ripping higher today after a cancer treatment breakthrough. Is Moderna stock a buy now?
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease
01:28pm, Tuesday, 13'th Dec 2022
"Now, we are an oncology company," Moderna CEO Stéphane Bancel told Insider.
Moderna shares get a boost from Merck vaccine combo
12:49pm, Tuesday, 13'th Dec 2022
Moderna Therapeutics Inc (NASDAQ:MRNA) shares rallied after the biotechnology firm told investors that a trial that combined its investigational cancer vaccine with drug giant Merck & Co Inc (NYSE:MRK
Trending Today: 5 Stocks in the News
12:48pm, Tuesday, 13'th Dec 2022
So far this week, several stocks have had headline-driven catalysts. We will cover 5 stocks trending in the news.
Moderna stock jumped 25% on a ‘big day for patients'
12:17pm, Tuesday, 13'th Dec 2022
Shares of Moderna Inc (NASDAQ: MRNA) are up nearly 25% on Tuesday after the biotech firm said its experimental vaccine for melanoma showed promising results in a small study.
Moderna will apply ‘same intensity' for cancer vaccine as it did for COVID, CEO says
12:00pm, Tuesday, 13'th Dec 2022
Moderna CEO Stéphane Bancel speaks with Yahoo Finance's Anjalee Khemlani about the company's MRNA skin cancer vaccine trial with Merck and the pipeline for producing cancer vaccines.
Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial
11:55am, Tuesday, 13'th Dec 2022
The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' risk by roughly 44%, versus just Keytruda.
Moderna and Merck team-up to fight melanoma
10:49am, Tuesday, 13'th Dec 2022
Vaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective treatment for skin cancer
